Vista AI, a provider of automated MRI scanning software for hospitals and imaging centers, has closed a $29.5 million Series B financing round backed by a mix of health systems and venture investors as it looks to scale its FDA-cleared cardiac MRI platform and broaden into additional anatomies.
New investors in the round include Cedars-Sinai Health System, Intermountain Health, University of Utah Hospital System, Temple University/Fox Chase Cancer Center, and Tampa General Hospital. The financing also included participation from existing backers, including Khosla Ventures, Bold Brain Capital, and other prior investors.
Vista AI says it is addressing a growing capacity constraint in radiology, arguing that MRI demand continues to outpace the availability of trained technologists—an imbalance that can drive longer wait times and additional operational strain for imaging providers. The company’s software is designed to automate key parts of the scanning workflow, aiming to standardize image quality while reducing variability and complexity for technologists.
With the new capital, Vista AI plans to build on its commercially available, FDA-cleared cardiac MRI offering by expanding into additional anatomies—specifically brain, prostate, and spine—pending FDA clearance. The company is also extending its product into remote scanning services, positioning the offering as a way for sites without deep cardiac MRI expertise or staffing to deliver advanced exams.
Vista AI highlighted results it says it has achieved in early deployments. At Brigham and Women’s Hospital, the company said its platform enabled 50% more cardiac MRI scan slots, eliminated a 28-day backlog, and supported next-day access without adding staff, scanners, or operating hours. At Radiology Regional, an imaging provider in Southwest Florida, Vista AI said the platform cut scan times by more than 50% and helped technologists without prior cardiac MRI experience deliver exams more consistently.
Over the past year, the company said it has expanded its customer base, strengthened its leadership team, and increased adoption across healthcare providers, as health system leaders and investors point to automation as a lever to expand access to advanced imaging while easing staffing pressures.
KEY QUOTES:
“Radiology is facing a critical bottleneck: demand for MRI far outstrips the supply of skilled technologists, overburdening staff and forcing delays for patients. Vista AI is breaking through that barrier by automating the scanning process, enabling technologists to consistently and efficiently deliver high-quality imaging, regardless of location.” “With this financing, we are not just scaling a company, we are scaling access to gold-standard diagnostic capability. By combining our automated MRI scanning software with remote scanning services, we can help healthcare organizations reduce backlogs, ease staff burden, and deliver consistently high-quality imaging to more patients than ever before.”
Daniel Hawkins, CEO, Vista AI
“Consistency in imaging quality translates directly into better patient care, and we are now able to provide that consistent standard of excellence across our system.”
Maureen Burgess, Partner, Cedars Sinai Health Ventures
“With demand rising and technologists in short supply, automation is the only way forward. Vista AI can extend advanced imaging beyond our main centers and make MRI accessible to more patients across our network.”
Dr. Blake Gardner, Senior Medical Director, Cardiovascular Clinical Program, Intermountain Health
“MRI is the backbone of modern diagnosis, yet access is constrained by workforce shortages and complexity. Vista AI is the only company directly addressing this issue with automation. That’s why leading health systems are investing—because Vista AI is on the path to becoming essential infrastructure in radiology.”
Bruce Armstrong, Partner, Khosla Ventures
